Dana Carroll, Ph.D.

Research Interests

  • Genome Engineering
  • TALENs
  • DNA Repair
  • CRISPRs
  • Zinc-Finger Nucleases

Labs

Lab Website

Languages

  • English

Academic Information

  • Departments: Biochemistry - Distinguished Professor
  • Cancer Center Programs: Nuclear Control of Cell Growth & Differentiation

Academic Office Information

  • (801) 581-5977
  • Emma Eccles Jones Research Building
    Biochemistry
    15 North Medical Drive East, Room: 4520B
    Salt Lake City, UT 84112

Academic Bio

Dana Carroll, PhD, is a Distinguished Professor in the Department of Biochemistry at the University of Utah School of Medicine and a member of the Nuclear Control of Cell Growth and Differentiation Program at the Huntsman Cancer Institute.

Carroll’s research involves making specific changes in chromosomal DNA using targetable nucleases. His lab pioneered the development of zinc-finger nucleases as gene targeting tools, and they have continued working with the more recent TALENs and CRISPR/Cas nucleases. Much of the effort has been focused on optimizing the efficiency of these reagents for targeted mutagenesis and gene replacement, which could ultimately provide treatment for many diseases, including certain types of cancer. This technology has now been applied to more than 40 different organisms, including current clinical trials in humans.

Carroll received his bachelor’s degree from Swarthmore College, Pennsylvania, and his PhD from the University of California, Berkeley. He did postdoctoral research at the Beatson Institute for Cancer Research in Glasgow, Scotland, at the Carnegie Institution Department of Embryology in Baltimore.

Education History

Type School Degree
Postdoctoral Fellowship Carnegie Institution of Washington
Department of Embryology, advisor: Donald D. Brown
Postdoctoral Fellow
Postdoctoral Fellowship Beatson Institute for Cancer Research
advisor: John Paul
Postdoctoral Fellow
Doctoral Training University of California, Berkeley
Department of Chemistry, thesis advisor: Ignacio Tinoco, Jr.
Ph.D.
Undergraduate Swarthmore College
Chemistry
B.A.

Global Impact

Education History

Type School Degree Country
Postdoctoral Fellowship Beatson Institute for Cancer Research
advisor: John Paul
Postdoctoral Fellow United Kingdom

Career

Institution Description Country
Edinburgh University, MRC Mammalian Genome Unit Visiting Scholar United Kingdom

Selected Publications

Journal Article

  1. A Perspective on the State of Genome Editing.Carroll D (2016). A Perspective on the State of Genome Editing. Mol Ther, 24(3), 412-3.
  2. Biotechnology. A prudent path forward for genomic engineering and germline gene modification.Baltimore D, Berg P, Botchan M, Carroll D, Charo RA, Church G, Corn JE, Daley GQ, Doudna JA, Fenner M, Greely HT, Jinek M, Martin GS, Penhoet E, Puck J, Sternberg SH, Weissman JS, Yamamoto KR (2015). Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science, 348(6230), 36-8.
  3. CRISPR germline engineering--the community speaks.Bosley KS, Botchan M, Bredenoord AL, Carroll D, Charo RA, Charpentier E, Cohen R, Corn J, Doudna J, Feng G, Greely HT, Isasi R, Ji W, Kim JS, Knoppers B, Lanphier E, Li J, Lovell-Badge R, Martin GS, Moreno J, Naldini L, Pera M, Perry AC, Venter JC, Zhang F, Zhou Q (2015). CRISPR germline engineering--the community speaks. Nat Biotechnol, 33(5), 478-86.
  4. The societal opportunities and challenges of genome editing.Carroll D, Charo RA (2015). The societal opportunities and challenges of genome editing. Genome Biol, 16(1), 242.
  5. Precision genome engineering.Carroll D (2014). Precision genome engineering. Curr Biol, 24(3), R102-3.
  6. Genome engineering with TALENs and ZFNs: repair pathways and donor design.Carroll D, Beumer KJ (2014). Genome engineering with TALENs and ZFNs: repair pathways and donor design. Methods, 69(2), 137-41.
  7. Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins.Cho SW, Lee J, Carroll D, Kim JS, Lee J (2013). Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics, 195(3), 1177-80.
  8. Comparing zinc finger nucleases and transcription activator-like effector nucleases for gene targeting in Drosophila.Beumer KJ, Trautman JK, Christian M, Dahlem TJ, Lake CM, Hawley RS, Grunwald DJ, Voytas DF, Carroll D (2013). Comparing zinc finger nucleases and transcription activator-like effector nucleases for gene targeting in Drosophila. G3 (Bethesda), 3(10), 1717-25.
  9. Staying on target with CRISPR-Cas.Carroll D (2013). Staying on target with CRISPR-Cas. Nat Biotechnol, 31(9), 807-9.
  10. Donor DNA Utilization during Gene Targeting with Zinc-finger Nucleases.LID - g3.112.005439v2 [pii]LID - 10.1534/g3.112.005439 [doi]Beumer KJ, Trautman JK, Mukherjee K, Carroll D (2013). Donor DNA Utilization during Gene Targeting with Zinc-finger Nucleases.LID - g3.112.005439v2 [pii]LID - 10.1534/g3.112.005439 [doi]. (Epub ahead of print) G3 (Bethesda).

Review

  1. Genome editing by targeted chromosomal mutagenesis.Carroll D (2015). Genome editing by targeted chromosomal mutagenesis. [Review]. Methods Mol Biol, 1239, 1-13.
  2. Origins of Programmable Nucleases for Genome Engineering.LID - S0022-2836(15)00606-3 [pii]LID - 10.1016/j.jmb.2015.10.014 [doi]Chandrasegaran S, Carroll D (2015). Origins of Programmable Nucleases for Genome Engineering.LID - S0022-2836(15)00606-3 [pii]LID - 10.1016/j.jmb.2015.10.014 [doi]. [Review]. J Mol Biol.
  3. Engineering nucleases for gene targeting: safety and regulatory considerations.Pauwels K, Podevin N, Breyer D, Carroll D, Herman P (2014). Engineering nucleases for gene targeting: safety and regulatory considerations. [Review]. New Biotechnology, 31(1), 18-27.
  4. Targeted genome engineering techniques in Drosophila.Beumer KJ, Carroll D (2014). Targeted genome engineering techniques in Drosophila. [Review]. Methods, 68(1), 29-37.
  5. Genome engineering with targetable nucleases.Carroll D (2014). Genome engineering with targetable nucleases. [Review]. Annu Rev Biochem, 83, 409-39.
  6. A CRISPR approach to gene targeting.Carroll D (2012). A CRISPR approach to gene targeting. [Review]. Mol Ther, 20(9), 1658-60.

Patent

  1. Carroll D, Bibikova M, Golic KG, Golic M, Drews GN (January 31, 2012). Target Chromosomal Mutagenesis Using Zinc Finger Nucleases. U.S. Patent No. 8106255. Washington, D.C.:U.S. Patent and Trademark Office.

News

Video